NEW YORK (GenomeWeb) – Dutch molecular diagnostics firm Agendia today announced that it and several partners have received a four-year, $6.8 million grant from the European Commission to study targeted therapies for colorectal cancer.
Registering provides access to this and other free content.
Already have an account?Login Now.
NPR reports that Turkish high school students will no longer study evolution.
Researchers report they sequenced and identified plant species in an "al fresco" laboratory.
An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.
In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.
In these times of economic constraint and increasing research costs, shared resource cores have become a cost-effective and essential platform for researchers who seek to investigate complex translational research questions.